Summary
SuperGen Inc., a drugmaker, delayed reporting third-quarter earnings so it can investigate $930,000 in potential liabilities.
The money represents personal income tax, penalties and interest involving a U.S. national who worked with the company in the U.K., SuperGen said Wednesday.See the full content of this document
Extract
Supergen Delays Quarterly Report
The Dublin, C...
See the full content of this document
Sponsored links
